Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

NCT ID: NCT06176196

Last Updated: 2025-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

218 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-13

Study Completion Date

2024-10-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Painful Lumbosacral Radiculopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VX-548

Participants will receive VX-548 up to 12 weeks.

Group Type EXPERIMENTAL

VX-548

Intervention Type DRUG

Tablets for oral administration.

Placebo

Participants will receive placebo matched to VX-548 up to 12 weeks.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Tablets for oral administration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VX-548

Tablets for oral administration.

Intervention Type DRUG

Placebo

Tablets for oral administration.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Suzetrigine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body weight greater than or equal to (\>=)45 kilogram (kg)
* Body mass index (BMI) less than or equal to (\<=) 40 kg/ meter square (m\^2)
* Diagnosis of PLSR for greater than (\>)3 months as per criteria pre-specified in the protocol
* Weekly average of daily NPRS score \>=4 and \<10 with limited variation in the 7-day Run-in Period

Exclusion Criteria

* More than 3 missing daily NPRS scores during the 7-day Run-in Period
* Moderate or severe painful neuropathy other than PLSR as pre-specified in the protocol
* History of prior lumbar spine surgery (e.g., discectomies, laminectomies, foraminotomies, or fusion)
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vertex Pharmaceuticals Incorporated

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hope Research Institute

Phoenix, Arizona, United States

Site Status

Arizona Research Center

Phoenix, Arizona, United States

Site Status

Trovare Clinical Research

Bakersfield, California, United States

Site Status

Velocity Clinical Research - Banning

Banning, California, United States

Site Status

Velocity Clinical Research - San Diego

La Mesa, California, United States

Site Status

Probe Clinical Research

Riverside, California, United States

Site Status

Pain Management and Injury Relief

Thousand Oaks, California, United States

Site Status

Visionary Investigators Network

Aventura, Florida, United States

Site Status

Nature Coast Clinical Research - Crystal River

Crystal River, Florida, United States

Site Status

JY Research Institute

Cutler Bay, Florida, United States

Site Status

Fleming Island Center for Clinical Research

Fleming Island, Florida, United States

Site Status

Convenient Medical Research

Hialeah, Florida, United States

Site Status

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States

Site Status

L&C Professional Medical Research Institute

Miami, Florida, United States

Site Status

Medical Research of Westchester

Miami, Florida, United States

Site Status

ARSN-Brain and Spine Institute

Port Orange, Florida, United States

Site Status

Accel Research Site - St. Petersburg/Largo

Seminole, Florida, United States

Site Status

Atlanta Center for Medical Research

Atlanta, Georgia, United States

Site Status

ClinCept Clinical Research

Columbus, Georgia, United States

Site Status

Accel Research Sites - Neurostudies

Decatur, Georgia, United States

Site Status

Velocity Clinical Research - Savannah Neurology Specialists

Savannah, Georgia, United States

Site Status

Velocity Clinical Research - Savannah

Savannah, Georgia, United States

Site Status

Center for Pain Management and Rehab

Stockbridge, Georgia, United States

Site Status

Velocity Clinical Research - Boise

Meridian, Idaho, United States

Site Status

Healthcare Research Network II, LLC

Flossmoor, Illinois, United States

Site Status

Essential Concepts Research Solutions

Palos Hills, Illinois, United States

Site Status

AMR Wichita East, KS

Wichita, Kansas, United States

Site Status

Velocity Clinical Research - Rockville

Rockville, Maryland, United States

Site Status

Brigham and Women's Hospital (BWH)

Boston, Massachusetts, United States

Site Status

MedVadis Research Coorporation

Waltham, Massachusetts, United States

Site Status

St. Louis Pain Consultants

Chesterfield, Missouri, United States

Site Status

Healthcare Research Network

Hazelwood, Missouri, United States

Site Status

Be Well Clinical Studies, LLC

Lincoln, Nebraska, United States

Site Status

Synexus Clinical Research - Henderson

Henderson, Nevada, United States

Site Status

AMR Las Vegas (Clinical Research Consortium)

Las Vegas, Nevada, United States

Site Status

Albany Medical Center

Albany, New York, United States

Site Status

AES New York

New York, New York, United States

Site Status

Velocity Clinical Research - Cincinnati

Cincinnati, Ohio, United States

Site Status

META Medical Research Institute

Dayton, Ohio, United States

Site Status

NexGen Research

Lima, Ohio, United States

Site Status

Clinical Investigations LLC.

Edmond, Oklahoma, United States

Site Status

AMR Norman

Norman, Oklahoma, United States

Site Status

Pacific Sports and Spine

Eugene, Oregon, United States

Site Status

Velocity Clinical Research - Grants Pass

Grants Pass, Oregon, United States

Site Status

Velocity Clinical Research - Providence

East Greenwich, Rhode Island, United States

Site Status

Clinical Trials of South Carolina - Charleston

Charleston, South Carolina, United States

Site Status

AES Dallas Forth Worth

Dallas, Texas, United States

Site Status

Expert Pain

Houston, Texas, United States

Site Status

Lubbock Spine Institute

Lubbock, Texas, United States

Site Status

Be Well Clinical Studies - Austin

Round Rock, Texas, United States

Site Status

JBR Clinical Research

Salt Lake City, Utah, United States

Site Status

Velocity Clinical Research - Hampton

Hampton, Virginia, United States

Site Status

AMR Norfolk

Norfolk, Virginia, United States

Site Status

Velocity Clinical Research - Portsmouth

Portsmouth, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VX23-548-109

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.